Executive summary of the American Radium Society® Appropriate Use Criteria for management of uterine carcinosarcoma.

Mednet Member

Gynecologic Oncology · Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center

This is a hard situation as there is no clear data for the exact treatment plan. For surgically staged patients with stage IIIC uterine cancer our tumor board treatment plans typically include discussion of PORTEC-3 (de Boer et al., PMID 31345626) and GOG-258 (Matei et al., PMID 31189035). Patients ...